Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines

Vaccine

Volumn 15, Issue 1, 1997, Pages 36-44

  Van Drunen Littel Van Den Hurk, S ^a   Tikoo, S K ^a   Van Den Hurk, J V ^a,b   Babiuk, L A ^a   Van Donkersgoed, J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Biostar Inc   (Canada)

Author keywords

bovine herpesvirus 1; conventional and marker vaccines; protection

Indexed keywords

HERPES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HERPES; IMMUNITY; INFECTION CONTROL; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; CATTLE; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; NEUTRALIZATION TESTS; VIRAL VACCINES;

EID: 0031020760     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00113-2     Document Type: Article

References (40)

1. 1 Gibbs, E.P.J. and Rweyemamu, M.M. Bovine herpesvirus. I. Bovine herpesvirus-1. Vet. Bull. (London) 1977, 47, 317
2. 2 Yates, W.D.G. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 1982, 46, 225
3. 3 Jericho, K.W.F., Yates, W.D.G. and Babiuk, L.A. Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection. Am. J. Vet. Res. 1982, 43, 1776
4. 4 Jensen, R., Pierson, R.E. and Braddy, P.M. Shipping fever pneumonia in yearling feedlot cattle. J. Am. Vet. Assoc. 1976, 169, 500
5. 5 Frerichs, G.N., Woods, S.B., Lucas, M.H. and Sands, J.J. Safety and efficacy of live and inactivated infectious rhinotracheitis vaccines. Vet. Rec. 1982, 111, 116
6. 6 Hyland, S.J., Easterday, B.C. and Pawlisch, R. Antibody levels and immunity to infectious bovine rhinotracheitis virus (IBR) infection in Wisconsin dairy cattle, Dev. Biol. Stand. 1974, 28, 510
7. 7 Mitchell, A. An outbreak of abortion in a dairy herd following inoculation with an intramuscular infectious bovine rhinotracheitis vaccine. Can. Vet. J. 1974, 15, 148
8. 8 Pastoret, P.P., Babiuk, L.A., Misra, V. and Griebel, P. Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis with dexamethasone. Infect. Immun. 1980, 29, 483
9. 9 Harland, R.J., Potter, A.A., van Drunen Littel-van den Hurk, S. ef al. The effect of sub-unit or modified live herpes virus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease. Can. Vet. J. 1992, 33, 734
10. 10 Whetstone, C.A., Wheeler, J.G. and Reed, D.E. Investigation of possible vaccine induced epizootics of infectious rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am. J. Vet. Res. 1986, 47, 1789
11. 11 Babiuk, L.A., L'Italien, J., van Drunen Littel-van den Hurk, S. et al. Protection of cattle from bovine herpesvirus type-1 (BHV-1) infection by immunization with individual glycoproteins. Virology 1987, 159, 57
12. 12 Van Drunen Littel-van den Hurk, S., Tikoo, S., Liang, X. and Babiuk, L.A. Bovine herpesvirus vaccines. Immun. Cell Biol. 1993, 71, 405
13. 13 Van Drunen Littel-van den Hurk, S. and Babiuk, L.A. Synthesis and processing of bovine herpesvirus-1 glycoproteins. J. Virol. 1986, 59, 401
14. 14 Whitbeck, J.C., Bello, L.J. and Lawrence, W.C. Comparison of the bovine herpesvirus gI gene and the herpes simplex virus type 1 gB gene. J. Virol. 1988, 62, 3319
15. 15 Fitzpatrick, D.R., Babiuk, L.A., Zamb, T.J. Nucleotide sequence of bovine herpesvirus type-1 glycoprotein gIII, a structural model for gIII as a new member of the immunoglobulin superfamily, and implications for the homologous glycoproteins of other herpesviruses. Virology 1989, 173, 46
16. 16 Tikoo, S.K., Fitzpatrick, D.R., Babiuk, L.A., Zamb, T.J. Molecular cloning, sequencing and expression of a functional bovine herpesvirus-1 glycoprotein gIV in transfected bovine cells. J. Virol. 1990, 64, 5132
17. 17 Van Drunen Littel-van den Hurk, S., Gifford, G.A. and Babiuk, L.A. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 1990, 8, 358
18. 18 Israel, B.A., Herber, R., Gao, Y. and Letchworth, G.J. Induction of a mucosal barrier to bovine herpesvirus-1 replication in cattle. Virology 1992, 188, 256
19. 19 Gao, Y., Leary, T.P., Eskra, L. and Splitter, G.A. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective immune response in its natural host. Vaccine 1994, 12, 145
20. 20 Hughes, G., Babiuk, L.A. and van Drunen Littel-van den Hurk, S. Functional and topographical analyses of epitopes on bovine herpesvirus-1 glycoprotein IV. Arch. Virol. 1988, 103, 47
21. 21 Liang, X., Babiuk, L.A., van Drunen Littel-van den Hurk, S., Fitzpatrick, D.R., Zamb, T.J. Bovine herpesvirus-1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J. Virol. 1991, 65, 1124
22. 22 Hutchings, D.L., van Drunen Littel-van den Hurk, S. and Babiuk, L.A. Lymphocyte proliferative responses to separate bovine herpesvirus-1 proteins in immune cattle. J. Virol. 1990, 64, 5114
23. 23 Van Drunen Littel-van den Hurk, S., Parker, M.D., Massie, B. et al. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 1993, 11, 25
24. 24 Tikoo, S.K., Zamb, T.J. and Babiuk, L.A. Analysis of bovine herpesvirus-1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 1993, 67, 2103
25. 25 Van Drunen Littel-van den Hurk, S., Zamb, T.J. and Babiuk, L.A. Synthesis, cellular location and immunogenicity of bovine herpesvirus-1 glycoproteins gI and gIII expressed by recombinant vaccinia virus. J. Virol. 1989, 63, 2159
26. 26 Cohen, G.M., Isola, V.J., Kuhns, J., Berman, P.W. and Eisenberg, R.J. Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("Native" gel) system of polyacrylamide gel elctrophoresis coupled with Western blotting. J. Virol. 1986, 60, 157
27. 27 Van Drunen Littel-van den Hurk, S., van den Hurk, J.V., Gilchrist, J.V., Misra, V. and Babiuk, L.A. Interactions of monoclonal antibodies and bovine herpesvirus type-1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 1984, 135, 466
28. 28 Van Drunen Littel-van den Hurk, S. and Babiuk, L.A. Antigenic and immunogenic characteristics of bovine herpesvirus type-1 glycoproteins GP3/9 and GP6/11a/16, purified by affinity chromatography. Virology 1985, 114, 204
29. 29 Osterrieder, N., Wagner, R., Pfeffer, M. and Kaaden, O.R. Expression of equine herpesvirus-1 glycoprotein gp14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune responses. J. Gen. Virol. 1994, 75, 2041
30. 30 Lehman, D.J., Roof, L.L., Brideau, R.J. et al. Comparison of soluble and secreted forms of human parainfluenza virus type 3 glycoproteins expressed from mammalian insect cells as subunit vaccines. J. Gen. Virol. 1993, 74, 459
31. 31 Hulst, M.M., Westra, D.F., Wensvoort, G. and Moorman, R.J.M. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera virus. J. Virol. 1993, 67, 5435
32. 32 Malvoisin, E. and Wild, F. Characterization of a secreted form of measles virus haemagglutinin expressed from a vaccinia virus recombinant. J. Gen. Virol. 1994, 75, 3603
33. 33 Delenda, C., Frenkiel, M.P. and Deubel, V. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells. Arch. Virol. 1994, 139, 197
34. 34 Seto, N.O.L., Ou, D. and Gillam, S. Expression and characterization of secreted forms of rubella virus E2 glycoprotein in insect cells. Virology 1995, 206, 736
35. 35 Van Donkersgoed, J. and Babiuk, L.A. Diagnosis and managing the respiratory form of infectious bovine rhinotracheitis. Vet. Med. 1991, 86, 86
36. 36 Flores, E.F., Osorio, F.A., Zanella, E.L., Kit, S. and Kit, M. Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serological differentiation from naturally infected animals. J. Diagn. Invest. 1993, 5, 534
37. 37 Kaashoek, M.J., Moerman, A., Madic, J. et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type-1 is an efficacious and safe vaccine. Vaccine 1994, 12, 439
38. 38 Kaashoek, M.J., Moerman, A., Madic, J. et al. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus-1 induces protective immunity and allows serological differentiation. Vaccine 1995, 13, 342
39. 39 Collins, J.K., Butcher, A.C. and Riegel, C.A. Immune response to bovine herpesvirus-1 type-1 infections: virus-specific antibodies in infected animals. J. Clin. Microbiol. 1985, 21, 546
40. 40 Van Drunen Littel-van den Hurk, S. and Babiuk, L.A. Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus-1. J. Clin. Microbiol. 1986, 23, 274